{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:21:43Z","timestamp":1787869303760,"version":"build-2784847793"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jfma.2021.10.006","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T12:28:41Z","timestamp":1635164921000},"page":"1117-1122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Down-regulation of miR-29c promotes the progression of oral submucous fibrosis through targeting tropomyosin-1"],"prefix":"10.1016","volume":"121","author":[{"given":"Po-Yu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis Chun-Yu","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8823-6840","authenticated-orcid":false,"given":"Szu-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ling","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo-Lin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2021.10.006_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.oraloncology.2008.05.016","article-title":"Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management","volume":"45","author":"van der Waal","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jfma.2021.10.006_bib2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/jcmm.12219","article-title":"Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1","volume":"18","author":"Chang","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jfma.2021.10.006_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/jpm11080707","article-title":"LINC00084\/miR-204\/ZEB1 axis mediates myofibroblastic differentiation activity in fibrotic buccal mucosa fibroblasts: therapeutic target for oral submucous fibrosis","volume":"11","author":"Lee","year":"2021","journal-title":"J Personalized Med"},{"key":"10.1016\/j.jfma.2021.10.006_bib4","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3390\/ijms22042216","article-title":"Targeting lncRNA H19\/miR-29b\/COL1A1 axis impedes myofibroblast activities of precancerous oral submucous fibrosis","volume":"22","author":"Yu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jfma.2021.10.006_bib5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jfma.2020.09.006","article-title":"LncRNA MEG3 inhibits self-renewal and invasion abilities of oral cancer stem cells by sponging miR-421","volume":"120","author":"Chen","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2021.10.006_bib6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1186\/s12885-018-4631-z","article-title":"Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer","volume":"18","author":"Lopes","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jfma.2021.10.006_bib7","doi-asserted-by":"crossref","first-page":"592415","DOI":"10.3389\/fonc.2020.592415","article-title":"Monocyte chemoattractant protein 1 promotes VEGF-A expression in OSCC by activating ILK and MEK1\/2 signaling and downregulating miR-29c","volume":"10","author":"Lien","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jfma.2021.10.006_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jfma.2017.09.012","article-title":"LncRNA GAS5-AS1 inhibits myofibroblasts activities in oral submucous fibrosis","volume":"117","author":"Lin","year":"2018","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2021.10.006_bib9","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: one function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jfma.2021.10.006_bib10","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.yexcr.2013.06.007","article-title":"Sp1 mediates microRNA-29c-regulated type I collagen production in renal tubular epithelial cells","volume":"319","author":"Jiang","year":"2013","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jfma.2021.10.006_bib11","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.bbadis.2019.06.004","article-title":"The Smad3-miR-29b\/miR-29c axis mediates the protective effect of macrophage migration inhibitory factor against cardiac fibrosis","volume":"1865","author":"Liang","year":"2019","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"10.1016\/j.jfma.2021.10.006_bib12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1165\/rcmb.2017-0133OC","article-title":"MicroRNA-29c prevents pulmonary fibrosis by regulating epithelial cell renewal and apoptosis","volume":"57","author":"Xie","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jfma.2021.10.006_bib13","doi-asserted-by":"crossref","first-page":"F595","DOI":"10.1152\/ajprenal.00634.2014","article-title":"Leukemia inhibitory factor attenuates renal fibrosis through Stat3-miR-29c","volume":"309","author":"Yu","year":"2015","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.jfma.2021.10.006_bib14","doi-asserted-by":"crossref","first-page":"L1050","DOI":"10.1152\/ajplung.00252.2016","article-title":"MicroRNA-29c regulates apoptosis sensitivity via modulation of the cell-surface death receptor, Fas, in lung fibroblasts","volume":"311","author":"Matsushima","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jfma.2021.10.006_bib15","doi-asserted-by":"crossref","first-page":"F1274","DOI":"10.1152\/ajprenal.00287.2012","article-title":"miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-\u03b1 activation","volume":"304","author":"Fang","year":"2013","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.jfma.2021.10.006_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fphys.2020.00331","article-title":"The MicroRNA MiR-29c alleviates renal fibrosis via TPM1-mediated suppression of the Wnt\/\u03b2-Catenin pathway","volume":"11","author":"Huang","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jfma.2021.10.006_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0955-0674(94)90122-8","article-title":"Functional properties of non-muscle tropomyosin isoforms","volume":"6","author":"Pittenger","year":"1994","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jfma.2021.10.006_bib18","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1083\/jcb.200708174","article-title":"Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling","volume":"179","author":"Morita","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jfma.2021.10.006_bib19","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/jcmm.13030","article-title":"FGF2 antagonizes aberrant TGF\u03b2 regulation of tropomyosin: role for posterior capsule opacity","volume":"21","author":"Kubo","year":"2017","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jfma.2021.10.006_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4161\/cc.8.2.7590","article-title":"Ras alters epithelial-mesenchymal transition in response to TGFbeta by reducing actin fibers and cell-matrix adhesion","volume":"8","author":"Safina","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jfma.2021.10.006_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12072-008-9113-y","article-title":"Induction of tropomyosin during hepatic stellate cell activation and the progression of liver fibrosis","volume":"3","author":"Otogawa","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jfma.2021.10.006_bib22","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/13880209.2020.1851729","article-title":"Arecoline suppresses epithelial cell viability by upregulating tropomyosin-1 through the transforming growth factor-\u03b2\/Smad pathway","volume":"58","author":"Li","year":"2020","journal-title":"Pharm Biol"},{"key":"10.1016\/j.jfma.2021.10.006_bib23","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1091\/mbc.e04-04-0353","article-title":"A critical role of tropomyosins in TGF-beta regulation of the actin cytoskeleton and cell motility in epithelial cells","volume":"15","author":"Bakin","year":"2004","journal-title":"Mol Biol Cell"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621004782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621004782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:47:06Z","timestamp":1760539626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664621004782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0929664621004782"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2021.10.006","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down-regulation of miR-29c promotes the progression of oral submucous fibrosis through targeting tropomyosin-1","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2021.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}